EXPLORE THE SCIENCE
TL;DR: Across 55 trials in low- and middle-income countries (5,041 adults), people who got therapy had much lower PTSD symptoms than people on a wait-list or other comparison. The evidence was very low certainty because many trials were weakly run. Key Finding…
Read article
TL;DR: A 2026 systematic review in PLOS One found that ketogenic diet therapies were linked to more 50% seizure reductions in drug-resistant epilepsy, with clearer evidence in children and more uncertainty for near-complete seizure control, side effects, adher…
Read article
TL;DR: A 2026 systematic review and meta-analysis in Journal of Medical Internet Research found that immersive virtual reality reduced anxiety and pain in randomized trials of gastrointestinal cancer care, but wide prediction intervals and low evidence certain…
Read article
TL;DR: A 2026 preprint on medRxiv found that in-person cognitive behavioral therapy for insomnia and several shorter behavioral versions were linked with higher post-treatment insomnia remission than sleep hygiene or other control conditions, but the evidence…
Read article
TL;DR: A 2026 meta-analysis in Journal of Medical Internet Research did not find a statistically significant reduction in Patient Health Questionnaire-9 (PHQ-9) depression scores with AI-driven chatbots, but emotionally responsive, structured, and frequent int…
Read article
TL;DR: A 2026 systematic review and meta-analysis in BMC Psychiatry reported that olanzapine produced a numerically higher body mass index gain in anorexia nervosa trials, but the pooled randomized evidence remained small, heterogeneous, and not statistically…
Read article
TL;DR: A 2026 systematic review and meta-analysis in Journal of Sleep Research found that agomelatine modestly improved subjective sleep quality versus placebo, but objective total sleep time did not significantly increase and somnolence reports were more freq…
Read article
TL;DR: A 2026 systematic review and exploratory network meta-analysis of 5 randomized trials in Neurological Sciences found dose-specific ON-medication motor improvements, measured while usual Parkinson’s drugs were active, for some GLP-1 receptor agonists, gl…
Read article
TLDR: Omega-3 supplementation shows potential for reducing anxiety symptoms, with the most significant improvement at a dose of 2 grams per day. Highlights: Dose-Dependent Effect: Each 1 gram per day of omega-3 supplementation led to a moderate decrease in anx…
Read article
Chamomile, a popular herbal tea, has frequently been associated with benefits for relaxation and sleep. A new systematic review and meta-analysis published in Phytotherapy Research comprehensively analyzes the clinical research on chamomile for anxiety, insomn…
Read article